Key facts
- CoFlo Medical’s last known valuation is $19.0M (Nov 2025).
- It has raised $500K across 1 recorded rounds; the latest was Seed Round ($500K) in Nov 2025.
- Notable investors include Massachusetts Institute of Technology.
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CoFlo Medical
Funding rounds
1 roundsAbout CoFlo Medical
Developer of drug delivery devices designed for the administration of high-viscosity and long-acting pharmaceutical formulations. The company's platform enables rapid injection of viscous drug solutions by overcoming injectability limitations, enabling pharmaceutical companies and healthcare providers to deliver high-dose therapies more efficiently and support the advancement of complex drug development.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 2
- Website
- coflo-medical.com/
- Ownership
- Privately Held (backing)
CoFlo Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CoFlo Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CoFlo Medical in its N-PORT filings yet. We sweep new filings monthly.